CDK4/6i can result in complete dephosphorylation of Rb, leading to inhibition of cell cycle progression by leading to non-release of the transcription factor E2F.[7] Figure 1 exhibited CDK4/6 inhibitors in cancer cells. Here, RB1 is linked to cancer.